Home MoleculeMind

MoleculeMind

In operation
Series A
AI Protein Design Platform Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

MoleculeMind continues to research and develop "AI Protein Prediction and Design" and has independently developed the AI large molecule optimization and design platform "MoleculeOS." By utilizing data-driven deep learning methods, it assists biotechnology experts in identifying and generating proteins to scale laboratory research results into industrial-level applications. This platform can be used for the research and design of peptides, antibodies, enzymes, and small proteins, transforming the development of large-molecule innovative drugs into a predictable and programmable process, thereby improving the efficiency of the entire drug development process. It can also be applied to protein optimization and design in fields such as chemistry, materials, industry, and agriculture.
MoleculeMind Inc.
Beijing,China
15~50 people
January 20, 2022
zhangying@moleculemind.ai

Enterprise Profile

Industrial Sector
Biomanufacturing New Drug Development CXO (Pharmaceutical Outsourcing Organization)
Technology
Artificial Intelligence Biotechnology Synthetic Biology
Application Scenarios
Innovative Drugs AI+Pharmaceuticals